Інформація опублікована з довідковою метою і не є рекламою, офертою, публічною пропозицією або керівництвом до застосування. Представлена виключно для інформування наших пацієнтів, які перебувають за кордоном. Сайт не здійснює жодної дистанційної торгівлі. Продаж, розповсюдження, доставка та призначення товарів через веб-ресурс не провадяться. Застосування товарів та медичних послуг можливе виключно за призначенням лікаря. Консультації надаються фахівцями клініки у очному форматі або за допомогою дистанційної медичної консультації у рамках чинного законодавства. Прошу звернути Вашу увагу, що у цьому довіднику продаж товарів програмно не передбачено.
• Infanrix Hexa is intended for the immunization of infants and young children.
• Vaccination typically starts at 6 weeks of age.
• It is not used in children older than approximately 3 years (depending on recommendations).
How it is administered — vaccination schedule
• Administered intramuscularly (usually in the front thigh for infants, in the deltoid muscle for older children).
• Course: 2–3 doses, with an interval of ≥ 1 month between doses (depending on the vaccination schedule).
• After the primary course, a booster may sometimes be required, depending on the immunization schedule.
Advantages
• Protection against six dangerous diseases with a single injection/course — convenient and reduces doctor visits.
• Effectiveness: the vaccine induces the production of protective antibodies against all components (diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, Hib).
• Quality and safety standards recognized in EU countries and worldwide.
Possible side effects
Like any vaccine, Infanrix Hexa may cause:
Common (in >1 in 10 doses):
• Redness, pain, swelling at the injection site
• Fever, mild fever or higher (up to approximately 38 °C)
• Reduced appetite, irritability, increased excitability or crying, lethargy, drowsiness in infants/children
• Sleep disturbance, fussiness
Occasionally:
• Vomiting, diarrhea, general weakness
Very rarely / with caution:
• Severe allergic reactions to vaccine components (including sensitivity to antibiotics used during production)
• Seizures, shock-like reactions, collapse, prolonged crying — in severe reactions to the pertussis component (rare).
Contraindications and precautions
Infanrix Hexa is not recommended / should not be used if:
• The child had a severe allergic reaction to any vaccine component, including trace residues of antibiotics (neomycin/polymyxin) or formaldehyde.
• There was a serious reaction after a previous pertussis-containing vaccine — for example, unexplained encephalopathy within 7 days after vaccination.
• The child has a severe acute infection or high fever — vaccination should be postponed until recovery.
Also, as with any vaccination: before the shot, the doctor assesses the child's condition. After vaccination, the child should be observed for about 30 minutes.
Why Infanrix Hexa is often chosen (comparison with DTP and other schedules)
• Unlike basic vaccines (e.g., simply DTP + poliomyelitis + hepatitis + Hib given separately), Infanrix Hexa provides combined protection against six infections at once.
• This saves doctor visits, minimizes the number of injections, and simplifies the immunization schedule.
• It creates reliable immunity starting from infancy, which is especially important during the early years of life.
• Vaccination typically starts at 6 weeks of age.
• It is not used in children older than approximately 3 years (depending on recommendations).
How it is administered — vaccination schedule
• Administered intramuscularly (usually in the front thigh for infants, in the deltoid muscle for older children).
• Course: 2–3 doses, with an interval of ≥ 1 month between doses (depending on the vaccination schedule).
• After the primary course, a booster may sometimes be required, depending on the immunization schedule.
Advantages
• Protection against six dangerous diseases with a single injection/course — convenient and reduces doctor visits.
• Effectiveness: the vaccine induces the production of protective antibodies against all components (diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, Hib).
• Quality and safety standards recognized in EU countries and worldwide.
Possible side effects
Like any vaccine, Infanrix Hexa may cause:
Common (in >1 in 10 doses):
• Redness, pain, swelling at the injection site
• Fever, mild fever or higher (up to approximately 38 °C)
• Reduced appetite, irritability, increased excitability or crying, lethargy, drowsiness in infants/children
• Sleep disturbance, fussiness
Occasionally:
• Vomiting, diarrhea, general weakness
Very rarely / with caution:
• Severe allergic reactions to vaccine components (including sensitivity to antibiotics used during production)
• Seizures, shock-like reactions, collapse, prolonged crying — in severe reactions to the pertussis component (rare).
Contraindications and precautions
Infanrix Hexa is not recommended / should not be used if:
• The child had a severe allergic reaction to any vaccine component, including trace residues of antibiotics (neomycin/polymyxin) or formaldehyde.
• There was a serious reaction after a previous pertussis-containing vaccine — for example, unexplained encephalopathy within 7 days after vaccination.
• The child has a severe acute infection or high fever — vaccination should be postponed until recovery.
Also, as with any vaccination: before the shot, the doctor assesses the child's condition. After vaccination, the child should be observed for about 30 minutes.
Why Infanrix Hexa is often chosen (comparison with DTP and other schedules)
• Unlike basic vaccines (e.g., simply DTP + poliomyelitis + hepatitis + Hib given separately), Infanrix Hexa provides combined protection against six infections at once.
• This saves doctor visits, minimizes the number of injections, and simplifies the immunization schedule.
• It creates reliable immunity starting from infancy, which is especially important during the early years of life.
